ProCE Banner Activity

CE / CME

Podcast 2: What’s New in Disease-Modifying Therapy

Podcast Episodes

In this podcast, multiple sclerosis (MS) experts Stephen Krieger, MD and Allison Boyd, MPAS, PA-C, MSCS discuss current data supporting the use of the many available disease-modifying therapies for MS and the importance of shared decision-making in providing optimal care for patients. To listen to the other podcasts in this series, please visit the program page.

Nurse Practitioners: 0.25 Nursing contact hours, includes 0.25 hour of pharmacotherapy credit

Physician Assistants/Physician Associates: 0.25 AAPA Category 1 CME credit

Released: December 30, 2022

Expiration: December 29, 2023

No longer available for credit.
Begin Activity

Share

Faculty

Allison L. Boyd

Allison L. Boyd, MPAS, PA-C, MSCS

Physician Assistant
Sentara Neurology
Virginia Beach, Virginia

Stephen Krieger

Stephen Krieger, MD

Professor of Neurology
Mount Sinai
New York, New York

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from

Genentech, a member of the Roche Group

Target Audience

NPs and PAs who care for patients with multiple sclerosis.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Develop evidence-based, individualized treatment strategies for patients with MS

Disclosure

All faculty and planners participating in continuing education activities sponsored by Partners for Advancing Clinical Education (PACE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PACE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Stephen Krieger, MD: consultant/advisor/speaker: Biogen, EMD Serono, Genentech, Genzyme/Sanofi, Novartis, Octave, TG Therapeutics; researcher: Biogen, Bristol-Myers Squibb, Novartis, Sanofi.

Allison L. Boyd, MPAS, PA-C, MSCS: consultant/advisor/speaker: EMD Serono.

Megan Weigel, DNP, APRM-C: consultant/advisor/speaker: Biogen Idec, Bristol-Myers Squibb, Horizon, Novartis, Sanofi Genzyme, TG Therapeutics

The planners and content peer reviewers from Partners for Advancing Clinical Education and Practicing Clinicians Exchange do not have any relevant financial relationships to disclose, except Megan Weigel, DNP, APRN-C as noted above.

Instructions for Credit

Learners wishing to earn CE/CME credit must:

  • Listen to the content in its entirety
  • Relate the content material to the learning objectives
  • Complete the post-test and evaluation form

Format

This program has been made available online.

Disclaimer

The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Partners for Advancing Clinical Education, Practicing Clinicians Exchange, or any educational supporter.

Accreditation

Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


ANCC Credit Designation

Nursing contact hours: 0.25, which includes 0.25 hours of pharmacology credit
NP Course Advisor: Megan Wiegel, DNP, ARNP-C

AAPA Credit Designation

Joint AccreditationPartners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until December 29, 2023. PAs should only claim credit commensurate with the extent of their participation.


IPCE Credit Designation
IPCEThis activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credits for learning and change.